Search results
Left in limbo: When pharma halts rare disease research
Pharmaceutical Technology· 6 days agoAnother huge challenge is the expensive commercial-grade manufacturing costs. “Commercial ...
Another huge challenge is the expensive commercial-grade manufacturing costs. “Commercial ...